Nanox Imaging is trading 5.96% up at $0.32 after hours, with no clear catalyst identified.

  • Shares closed at $0.30 on November 2, 2026, after declining 8.51% during the regular session.
  • Nanox announced updated clinical data for its investigational AVC software at the TCT conference on November 2.
  • The software remains under development and is not cleared for clinical use; available reporting does not establish that the announcement caused the after-hours move.